| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM PRESIDENT AND CEO | Apr 01, 2024 | Option Exercise | $1.26 | 3,224 | 4,062 | 1,285,688 | Apr 03, 2024, 05:00 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | Interim President and CEO | Mar 01, 2024 | Option Exercise | $1.24 | 3,223 | 3,997 | 1,279,445 | Mar 05, 2024, 05:08 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | Mar 02, 2024 | Option Exercise | $1.24 | 3,531 | 4,378 | 186,783 | Mar 05, 2024, 05:04 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | Mar 01, 2024 | Option Exercise | $1.24 | 17,752 | 22,012 | 177,814 | Mar 05, 2024, 05:04 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Balthaser Kevin | Chief Financial Officer | Mar 01, 2024 | Option Exercise | $1.24 | 990 | 1,228 | 22,910 | Mar 05, 2024, 05:02 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Balthaser Kevin | Chief Financial Officer | Mar 02, 2024 | Option Exercise | $1.24 | 427 | 529 | 23,983 | Mar 05, 2024, 05:02 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | Feb 01, 2024 | Option Exercise | $1.20 | 2,583 | 3,100 | 134,641 | Feb 05, 2024, 07:31 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Loerop James | Chief Business Officer | Feb 01, 2024 | Option Exercise | $1.20 | 6,421 | 7,705 | 34,017 | Feb 05, 2024, 07:29 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Manion Douglas J. | Pres and CEO | Jan 01, 2024 | Option Exercise | $1.05 | 9,125 | 9,581 | 41,813 | Jan 03, 2024, 04:44 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | Oct 23, 2023 | Sale | $5.08 | 6,000 | 30,460 | 129,724 | Oct 25, 2023, 04:28 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Balthaser Kevin | Chief Financial Officer | Sep 06, 2023 | Buy | $7.90 | 9,490 | 74,971 | 15,461 | Sep 07, 2023, 04:16 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Balthaser Kevin | Chief Financial Officer | Sep 01, 2023 | Option Exercise | $7.90 | 285 | 2,252 | 5,971 | Sep 05, 2023, 05:08 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Loerop James | Chief Business Officer | Aug 28, 2023 | Buy | $6.80 | 14,705 | 99,959 | 21,688 | Aug 28, 2023, 04:39 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | Aug 21, 2023 | Sale | $7.32 | 6,000 | 43,895 | 135,724 | Aug 22, 2023, 04:31 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Manion Douglas J. | Pres and CEO | Aug 01, 2023 | Option Exercise | $9.81 | 4,437 | 43,527 | 23,938 | Aug 03, 2023, 04:24 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Molineaux Christopher P. | Director | Jun 20, 2023 | Option Exercise | $1.41 | 16,500 | 23,265 | 48,503 | Jun 22, 2023, 04:32 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | Jun 20, 2023 | Sale | $10.28 | 6,000 | 61,663 | 141,724 | Jun 22, 2023, 04:30 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Molineaux Christopher P. | Director | Jun 15, 2023 | Option Exercise | $1.36 | 249 | 338 | 32,003 | Jun 20, 2023, 04:31 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Manion Douglas J. | Pres and CEO | Mar 17, 2023 | Buy | $7.86 | 6,300 | 49,532 | 12,800 | Mar 17, 2023, 05:03 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Manion Douglas J. | Pres and CEO | Mar 09, 2023 | Buy | $7.74 | 6,500 | 50,278 | 6,500 | Mar 09, 2023, 05:56 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | Director | Mar 02, 2023 | Sale | $12.37 | 29,000 | 358,588 | 1,285,188 | Mar 03, 2023, 08:37 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | Director | Mar 03, 2023 | Sale | $12.63 | 30,240 | 382,070 | 1,273,202 | Mar 03, 2023, 08:37 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | Mar 03, 2023 | Sale | $12.63 | 16,037 | 202,615 | 147,724 | Mar 03, 2023, 08:12 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | Mar 02, 2023 | Sale | $12.37 | 14,800 | 183,024 | 151,261 | Mar 03, 2023, 08:12 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Balthaser Kevin | Chief Financial Officer | Mar 02, 2023 | Sale | $12.29 | 1,000 | 12,289 | 4,650 | Mar 03, 2023, 08:09 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Balthaser Kevin | Chief Financial Officer | Mar 03, 2023 | Sale | $12.63 | 894 | 11,290 | 5,256 | Mar 03, 2023, 08:09 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | Feb 15, 2023 | Sale | $13.06 | 5,000 | 65,311 | 91,386 | Feb 17, 2023, 04:34 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Loerop James | Chief Business Officer | Feb 08, 2023 | Sale | $13.89 | 4,267 | 59,272 | 6,983 | Feb 10, 2023, 04:55 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | Director | Feb 02, 2023 | Sale | $16.25 | 5,000 | 81,248 | 1,179,684 | Feb 03, 2023, 05:09 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | Director | Feb 01, 2023 | Sale | $16.75 | 25,000 | 418,675 | 1,180,763 | Feb 03, 2023, 05:09 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | Director | Jan 03, 2023 | Sale | $15.25 | 25,000 | 381,213 | 1,222,381 | Jan 04, 2023, 06:20 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | Director | Jan 04, 2023 | Sale | $14.89 | 15,000 | 223,342 | 1,205,763 | Jan 04, 2023, 06:20 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | Dec 15, 2022 | Sale | $15.88 | 5,000 | 79,412 | 96,386 | Dec 16, 2022, 04:57 PM | |
| ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Director | Nov 14, 2022 | Sale | $17.08 | 1,371 | 23,417 | 434,455 | Nov 14, 2022, 04:51 PM | |
| ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Director | Nov 10, 2022 | Sale | $17.02 | 11,395 | 193,995 | 476,986 | Nov 14, 2022, 04:51 PM | |
| ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Director | Nov 11, 2022 | Sale | $17.06 | 41,160 | 702,177 | 435,826 | Nov 14, 2022, 04:51 PM | |
| ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Director | Oct 24, 2022 | Sale | $17.01 | 14,616 | 248,586 | 514,939 | Oct 26, 2022, 07:09 PM | |
| ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Director | Oct 25, 2022 | Sale | $17.02 | 12,018 | 204,516 | 502,921 | Oct 26, 2022, 07:09 PM | |
| ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Director | Oct 26, 2022 | Sale | $17.00 | 14,540 | 247,253 | 488,381 | Oct 26, 2022, 07:09 PM | |
| ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Director | Oct 17, 2022 | Sale | $16.05 | 19,944 | 320,087 | 561,648 | Oct 19, 2022, 04:49 PM | |
| ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Director | Oct 18, 2022 | Sale | $16.89 | 32,093 | 542,022 | 529,555 | Oct 19, 2022, 04:49 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | Oct 17, 2022 | Sale | $15.98 | 5,000 | 79,907 | 101,386 | Oct 19, 2022, 04:45 PM | |
| ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Director | Oct 07, 2022 | Sale | $16.16 | 7,324 | 118,349 | 581,592 | Oct 11, 2022, 04:35 PM | |
| ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Director | Oct 04, 2022 | Sale | $16.01 | 7,700 | 123,259 | 626,755 | Oct 06, 2022, 05:58 PM | |
| ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Director | Oct 06, 2022 | Sale | $16.54 | 37,839 | 625,744 | 588,916 | Oct 06, 2022, 05:58 PM | |
| ACRS | Aclaris Therapeutics, Inc. | SCHIFF ANDREW N | Director | Jun 17, 2022 | Sale | $15.14 | 19,565 | 296,269 | 0 | Jun 21, 2022, 04:57 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | President and CEO | Apr 21, 2022 | Sale | $15.24 | 25,000 | 380,947 | 1,290,763 | Apr 25, 2022, 05:13 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | President and CEO | Apr 22, 2022 | Sale | $15.04 | 25,000 | 376,097 | 1,265,763 | Apr 25, 2022, 05:13 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | President and CEO | Apr 25, 2022 | Sale | $15.18 | 20,000 | 303,656 | 1,245,763 | Apr 25, 2022, 05:13 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | Apr 18, 2022 | Sale | $16.28 | 30,000 | 488,298 | 106,386 | Apr 20, 2022, 05:06 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | President and CEO | Mar 11, 2022 | Sale | $15.91 | 56,303 | 896,045 | 1,315,763 | Mar 14, 2022, 04:58 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Mar 10, 2022 | Sale | $15.55 | 12,823 | 199,335 | 201,883 | Mar 14, 2022, 04:56 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | Mar 10, 2022 | Sale | $15.71 | 27,165 | 426,803 | 136,386 | Mar 14, 2022, 04:53 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | Feb 09, 2022 | Sale | $12.68 | 383 | 4,857 | 87,301 | Feb 11, 2022, 04:22 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Feb 09, 2022 | Sale | $12.66 | 1,388 | 17,568 | 172,359 | Feb 11, 2022, 04:18 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | President and CEO | Feb 09, 2022 | Sale | $12.66 | 3,595 | 45,513 | 1,239,387 | Feb 11, 2022, 04:15 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | Sep 01, 2021 | Option Exercise | $17.22 | 1,041 | 17,926 | 86,634 | Sep 02, 2021, 05:39 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Gordon David N. | Chief Medical Officer | Jul 13, 2021 | Sale | $16.98 | 2,631 | 44,675 | 147,447 | Jul 14, 2021, 05:32 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ali-Jackson Kamil | Chief Legal Officer | Jun 03, 2021 | Sale | $21.96 | 9,492 | 208,421 | 122,196 | Jun 04, 2021, 07:52 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Gordon David N. | Chief Medical Officer | Jun 01, 2021 | Sale | $23.01 | 14,000 | 322,165 | 186,877 | Jun 02, 2021, 09:49 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Gordon David N. | Chief Medical Officer | Jun 02, 2021 | Sale | $21.63 | 37,914 | 820,209 | 150,878 | Jun 02, 2021, 09:49 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ali-Jackson Kamil | Chief Legal Officer | Jun 01, 2021 | Sale | $23.02 | 15,000 | 345,299 | 167,061 | Jun 02, 2021, 09:47 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ali-Jackson Kamil | Chief Legal Officer | Jun 02, 2021 | Sale | $21.64 | 30,119 | 651,664 | 149,324 | Jun 02, 2021, 09:47 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Monahan Joseph | Chief Scientific Officer | Jun 02, 2021 | Sale | $21.64 | 21,790 | 471,437 | 88,892 | Jun 02, 2021, 09:45 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Jun 02, 2021 | Sale | $21.64 | 15,037 | 325,383 | 172,322 | Jun 02, 2021, 09:43 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | President and CEO | Jun 02, 2021 | Sale | $21.64 | 33,260 | 719,735 | 1,237,699 | Jun 02, 2021, 09:41 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Apr 22, 2021 | Sale | $26.84 | 30,000 | 805,218 | 209,059 | Apr 26, 2021, 09:45 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Apr 23, 2021 | Sale | $26.66 | 30,000 | 799,660 | 179,859 | Apr 26, 2021, 09:45 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Apr 26, 2021 | Sale | $25.80 | 27,339 | 705,228 | 151,820 | Apr 26, 2021, 09:45 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | President and CEO | Apr 22, 2021 | Sale | $26.84 | 30,000 | 805,239 | 1,192,427 | Apr 26, 2021, 09:43 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Gordon David N. | Chief Medical Officer | Mar 01, 2021 | Option Exercise | $24.06 | 5,660 | 136,180 | 102,475 | Mar 03, 2021, 08:42 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Gordon David N. | Chief Medical Officer | Mar 02, 2021 | Option Exercise | $23.25 | 2,280 | 53,010 | 108,492 | Mar 03, 2021, 08:42 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ali-Jackson Kamil | Chief Legal Officer | Mar 02, 2021 | Option Exercise | $23.25 | 1,906 | 44,315 | 143,618 | Mar 03, 2021, 08:39 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ali-Jackson Kamil | Chief Legal Officer | Mar 01, 2021 | Option Exercise | $24.06 | 4,934 | 118,712 | 138,887 | Mar 03, 2021, 08:39 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Mar 01, 2021 | Option Exercise | $24.06 | 7,333 | 176,432 | 233,606 | Mar 03, 2021, 08:36 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Mar 02, 2021 | Option Exercise | $23.25 | 2,844 | 66,123 | 239,059 | Mar 03, 2021, 08:36 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | President and CEO | Mar 01, 2021 | Option Exercise | $24.06 | 39,792 | 957,395 | 1,212,156 | Mar 03, 2021, 08:32 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | President and CEO | Mar 02, 2021 | Option Exercise | $23.25 | 7,982 | 185,582 | 1,222,427 | Mar 03, 2021, 08:32 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Mehra Anand | Director | Feb 02, 2021 | Option Exercise | $18.34 | 14,632 | 268,298 | 30,841 | Feb 03, 2021, 05:33 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Feb 01, 2021 | Option Exercise | $21.35 | 1,308 | 27,926 | 215,189 | Feb 03, 2021, 05:29 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ali-Jackson Kamil | Chief Legal Officer | Feb 01, 2021 | Option Exercise | $21.35 | 1,318 | 28,139 | 126,646 | Feb 03, 2021, 05:26 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | President and CEO | Feb 01, 2021 | Option Exercise | $21.35 | 3,316 | 70,797 | 1,155,798 | Feb 03, 2021, 05:23 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | President and CEO | Dec 15, 2020 | Option Exercise | $4.59 | 871 | 3,998 | 1,148,314 | Dec 17, 2020, 05:08 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Dec 15, 2020 | Option Exercise | $4.59 | 370 | 1,698 | 212,622 | Dec 17, 2020, 05:07 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ali-Jackson Kamil | Chief Legal Officer | Dec 15, 2020 | Option Exercise | $4.59 | 498 | 2,286 | 124,089 | Dec 17, 2020, 05:06 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | President and CEO | Sep 01, 2020 | Option Exercise | $2.33 | 23,872 | 55,622 | 1,146,151 | Sep 03, 2020, 04:23 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Gordon David N. | Chief Medical Officer | Jul 02, 2020 | Option Exercise | $1.50 | 1,360 | 2,040 | 87,535 | Jul 07, 2020, 07:25 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | President and CEO | Jun 01, 2020 | Option Exercise | $1.32 | 20,976 | 27,688 | 1,086,931 | Jun 03, 2020, 04:47 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Jun 01, 2020 | Option Exercise | $1.32 | 9,451 | 12,475 | 211,692 | Jun 03, 2020, 04:45 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Gordon David N. | Chief Medical Officer | Jun 01, 2020 | Option Exercise | $1.32 | 24,045 | 31,739 | 82,895 | Jun 03, 2020, 04:43 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ali-Jackson Kamil | Chief Legal Officer | Jun 01, 2020 | Option Exercise | $1.32 | 9,534 | 12,585 | 122,853 | Jun 03, 2020, 04:42 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | President and CEO | Mar 02, 2020 | Option Exercise | $1.26 | 42,724 | 53,832 | 1,034,893 | Mar 04, 2020, 04:30 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Mar 02, 2020 | Option Exercise | $1.26 | 7,162 | 9,024 | 187,955 | Mar 04, 2020, 04:30 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ali-Jackson Kamil | Chief Legal Officer | Mar 02, 2020 | Option Exercise | $1.26 | 4,779 | 6,022 | 99,199 | Mar 04, 2020, 04:22 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Gordon David N. | Chief Medical Officer | Mar 02, 2020 | Option Exercise | $1.26 | 5,512 | 6,945 | 19,440 | Mar 04, 2020, 04:20 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | President and CEO | Feb 03, 2020 | Option Exercise | $1.28 | 3,675 | 4,704 | 928,903 | Feb 04, 2020, 07:13 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Feb 03, 2020 | Option Exercise | $1.28 | 1,308 | 1,674 | 169,367 | Feb 04, 2020, 07:12 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ali-Jackson Kamil | Chief Legal Officer | Feb 03, 2020 | Option Exercise | $1.28 | 1,318 | 1,687 | 86,803 | Feb 04, 2020, 07:11 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Walker Neal | President and CEO | Dec 18, 2019 | Option Exercise | $1.81 | 743 | 1,345 | 921,778 | Dec 20, 2019, 04:19 PM | |
| ACRS | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Dec 18, 2019 | Option Exercise | $1.81 | 356 | 644 | 166,800 | Dec 20, 2019, 04:18 PM |
Menu